Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $6.00 million. The enterprise value is $4.98 million.

Market Cap	6.00M
Enterprise Value	4.98M

Important Dates

The next estimated earnings date is Friday, February 7, 2025, after market close.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 3.47 million shares outstanding. The number of shares has increased by 11.84% in one year.

Current Share Class	3.47M
Shares Outstanding	3.47M
Shares Change (YoY)	+11.84%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	16.93%
Owned by Institutions (%)	4.65%
Float	2.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.84
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.01.

Current Ratio	0.91
Quick Ratio	0.71
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -136.66% and return on invested capital (ROIC) is -95.89%.

Return on Equity (ROE)	-136.66%
Return on Assets (ROA)	-69.02%
Return on Capital (ROIC)	-95.89%
Revenue Per Employee	n/a
Profits Per Employee	-$385,628
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.26% in the last 52 weeks. The beta is 0.79, so Edesa Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-65.26%
50-Day Moving Average	2.66
200-Day Moving Average	4.02
Relative Strength Index (RSI)	31.43
Average Volume (20 Days)	30,805

Short Selling Information

The latest short interest is 35,490, so 1.02% of the outstanding shares have been sold short.

Short Interest	35,490
Short Previous Month	48,461
Short % of Shares Out	1.02%
Short % of Float	1.30%
Short Ratio (days to cover)	0.76

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.01M
Pretax Income	-6.93M
Net Income	-6.17M
EBITDA	-6.90M
EBIT	-7.01M
Earnings Per Share (EPS)	-$1.93

Full Income Statement

Balance Sheet

The company has $1.04 million in cash and $19,867 in debt, giving a net cash position of $1.02 million or $0.29 per share.

Cash & Cash Equivalents	1.04M
Total Debt	19,867
Net Cash	1.02M
Net Cash Per Share	$0.29
Equity (Book Value)	1.98M
Book Value Per Share	0.61
Working Capital	-157,205

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.89M
Capital Expenditures	n/a
Free Cash Flow	-4.89M
FCF Per Share	-$1.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.84%
Shareholder Yield	-11.84%
Earnings Yield	-102.85%
FCF Yield	-81.52%

Analyst Forecast

The average price target for Edesa Biotech is $21.00, which is 1,113.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	1,113.87%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 0.1428571:1.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	0.1428571:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1